Gotham City Research has released a new report titled ‘How an advance becomes a loan’ that focuses on the relationship between Grifols and related companies such as Scranton, BPC Plasma, and Haema. The New York bearish analysis and investor firm released this report just before Grifols’ quarterly results announcement, which caused a 4% drop in the company’s shares.
The report delves into BPC Plasma, one of the companies acquired by Grifols in 2018 and later sold to Scranton, a related company with ties to the Grifols family. Gotham accuses BPC of lending funds received from a third party (likely Grifols) to Scranton, with no intention of repayment. This highlights a governance failure and suggests that the Grifols family is benefiting at the expense of Grifols’ shareholders.
Recent disclosures by Grifols regarding their relationships with related companies have only added fuel to Gotham’s accusations. Despite implementing measures to separate powers within the company, Grifols has come under scrutiny for its dealings with related entities. President Thomas Glazmann defends the company’s transparency and quick response to these allegations but acknowledges the challenges posed by Gotham’s attacks.
In the midst of these controversies, other topics like nootropics and organic lithium for depression have been gaining attention in the health and wellness community. Nootropicology, a platform focusing on cognitive enhancers and brain-boosting supplements, provides insights and reviews on various products in this space. With a growing interest in mental well-being and performance, these topics continue to be of relevance and interest to many.
+ There are no comments
Add yours